Skip to main content
رجوع
BDX logo

Becton, Dickinson and Company

جودة البيانات: 100%
BDX
NYSE Healthcare Medical - Instruments & Supplies
KWD 155.92
▼ KWD 0.31 (-0.20%)
القيمة السوقية: 56.49B
نطاق اليوم
KWD 154.45 KWD 157.05
نطاق 52 أسبوعًا
KWD 127.59 KWD 187.35
حجم التداول
2,218,350
متوسط 50 يوم / 200 يوم
KWD 166.77 / KWD 151.59
الإغلاق السابق
KWD 156.23

تاريخ السعر

الاتجاهات المالية

مقارنة الأقران

مقابل وسيط قطاع Healthcare (627 نظير)

المقياس السهم وسيط القطاع
P/E 33.7 0.4
P/B 2.2 2.9
ROE % 6.5 3.7
Net Margin % 7.7 3.9
Rev Growth 5Y % 3.4 10.0
D/E 0.8 0.2

السعر المستهدف للمحللين

Hold
KWD 193.800 +24.3%
Low: KWD 170.000 High: KWD 215.000
مكرر الربحية المستقبلي
12.5
ربحية السهم المستقبلية
KWD 12.524
نمو ربحية السهم (تقدير)
+0.0%
الإيرادات المقدّرة
19 B

تقديرات الأرباح

الفترة تقدير ربحية السهم تقدير الإيرادات المحللون
FY2030 KWD 16.910
KWD 16.751 – KWD 17.260
22 B 1
FY2029 KWD 15.630
KWD 15.483 – KWD 15.954
21 B 1
FY2028 KWD 14.290
KWD 14.155 – KWD 14.586
20 B 1

النقاط الرئيسية

Revenue grew 3.37% annually over 5 years — modest growth
Generating 2.67B in free cash flow
P/E of 33.66 — premium valuation
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 4.86%
Cash machine — converts 159.12% of earnings into free cash flow
Capital efficient — spends only 3.48% of revenue on capex

النمو

Revenue Growth (5Y)
3.37%
Revenue (1Y)8.23%
Earnings (1Y)-1.58%
FCF Growth (3Y)12.36%

الجودة

Return on Equity
6.54%
ROIC4.34%
Net Margin7.68%
Op. Margin11.80%

الأمان

Debt / Equity
0.76
Current Ratio1.11
Interest Coverage4.21

التقييم

P/E Ratio
33.66
P/B Ratio2.22
EV/EBITDA29.02
Dividend Yield0.04%

All Fundamental Metrics

Growth
Revenue Growth (1Y) 8.23% Revenue Growth (3Y) 6.18%
Earnings Growth (1Y) -1.58% Earnings Growth (3Y) 6.34%
Revenue Growth (5Y) 3.37% Earnings Growth (5Y) -5.36%
Profitability
Revenue (TTM) 21.84B Net Income (TTM) 1.68B
ROE 6.54% ROA 3.03%
Gross Margin 45.44% Operating Margin 11.80%
Net Margin 7.68% Free Cash Flow (TTM) 2.67B
ROIC 4.34% FCF Growth (3Y) 12.36%
Safety
Debt / Equity 0.76 Current Ratio 1.11
Interest Coverage 4.21 Dividend Yield 0.04%
Valuation
P/E Ratio 33.66 P/B Ratio 2.22
P/S Ratio 2.59 PEG Ratio -29.05
EV/EBITDA 29.02 Dividend Yield 0.04%
Market Cap 56.49B Enterprise Value 74.82B

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 21.84B 20.18B 19.37B 18.87B 19.13B
Net Income 1.68B 1.71B 1.48B 1.78B 2.09B
EPS (Diluted) 5.83 5.86 4.94 5.88 6.85
Gross Profit 9.92B 9.13B 8.17B 8.48B 8.63B
Operating Income 2.58B 2.40B 2.11B 2.28B 2.25B

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 55.33B 57.29B 52.78B 52.93B 53.88B
Total Liabilities 29.94B 31.40B 26.98B 27.65B 30.20B
Shareholders' Equity 25.39B 25.89B 25.80B 25.28B 23.68B
Total Debt 19.18B 21.59B 16.82B 16.95B 18.42B
Cash & Equivalents 851.00M 1.86B 1.42B 1.16B 2.39B
Current Assets 9.26B 10.47B 8.68B 8.14B 8.84B
Current Liabilities 8.31B 8.96B 6.64B 7.81B 6.63B

درجات الاستراتيجيات

This stock passed the criteria for 1 strategy

Score = fit strength (0–100)
Rank = position among all matches
#381 of 1052
51

النشاط الأخير

دخل Cash Flow Compounder
Mar 24, 2026